Targeting this periostin-mediated pathway, perhaps through inhibition of integrinβ1 and/or the ERK signal, might be beneficial for those bladder cancer patients who have elevated urinary EV periostin. The gene discussed is POSTN; the disease is urinary bladder cancer.